| Foreword |
ix |
| Preface |
xi |
| Chapter 1. Cardiac Tamponade |
1 |
| Introduction |
1 |
| Incidence |
1 |
| Risk Factors |
2 |
| Pathophysiology |
4 |
| Clinical Manifestations |
7 |
| Patient Assessment |
10 |
| Diagnostic Evaluation |
12 |
| Treatment Modalities |
16 |
| Nursing Management |
24 |
| Patient and Caregiver Educationt |
26 |
| Conclusion |
27 |
| References |
27 |
| Chapter 2. Disseminated Intravascular Coagulation |
31 |
| Introduction |
31 |
| Incidence |
32 |
| Risk Factors |
35 |
| Pathophysiology |
36 |
| Clinical Manifestations |
39 |
| Patient Assessment |
40 |
| Diagnostic Evaluation |
40 |
| Treatment Modalities |
45 |
| Nursing Management |
47 |
| Patient and Caregiver Education |
48 |
| Conclusion |
48 |
| References |
48 |
| Chapter 3. Hypercalcemia of Malignancy |
51 |
| Introduction |
51 |
| Incidence |
51 |
| Risk Factors |
52 |
| Normal Calcium Homeostasis |
52 |
| Normal Bone Remodeling and Effects of Metastatic Disease |
61 |
| Pathophysiology |
64 |
| Clinical Manifestations |
69 |
| Patient Assessment |
72 |
| Diagnostic Evaluation |
73 |
| Treatment Modalities |
74 |
| Nursing Management |
90 |
| End-of-Life Considerations |
93 |
| Patient and Caregiver Education |
93 |
| Conclusion |
94 |
| References |
94 |
| Chapter 4. Increased Intracranial Pressure |
99 |
| Introduction |
99 |
| Incidence |
99 |
| Risk Factors |
101 |
| Normal Brain Physiology |
103 |
| Pathophysiology |
106 |
| Clinical Manifestations |
108 |
| Patient Assessment |
110 |
| Diagnostic Evaluation |
112 |
| Treatment Modalities |
114 |
| Nursing Management |
117 |
| Patient and Caregiver Education |
120 |
| Conclusion |
120 |
| References |
120 |
| Chapter 5. Malignant Pleural Effusion |
123 |
| Introduction |
123 |
| Incidence |
123 |
| Risk Factors |
125 |
| Pathophysiology |
127 |
| Clinical Manifestations |
128 |
| Patient Assessment |
129 |
| Diagnostic Evaluation |
130 |
| Treatment Modalities |
135 |
| Nursing Management |
149 |
| Patient and Caregiver Education |
152 |
| Conclusion |
153 |
| References |
153 |
| Chapter 6. Sepsis and Septic Shock |
159 |
| Introduction |
159 |
| Definitions |
159 |
| Incidence |
161 |
| Risk Factors |
162 |
| Pathophysiology |
162 |
| Clinical Manifestations |
165 |
| Patient Assessment |
166 |
| Diagnostic Evaluation |
169 |
| Treatment Modalities |
173 |
| Nursing Management |
185 |
| Patient and Caregiver Education |
190 |
| Conclusion |
191 |
| References |
191 |
| Chapter 7. Syndrome of Inappropriate Antidiuretic Hormone Secretion |
197 |
| Introduction |
197 |
| Incidence |
197 |
| Normal Physiology of Water Regulation |
198 |
| Pathophysiology |
200 |
| Risk Factors |
201 |
| Clinical Manifestations |
204 |
| Patient Assessment |
206 |
| Diagnostic Evaluation |
207 |
| Treatment Modalities |
208 |
| Nursing Management |
211 |
| Patient and Caregiver Education |
215 |
| Conclusion |
215 |
| References |
216 |
| Chapter 8. Spinal Cord Compression |
219 |
| Incidence |
220 |
| Risk Factors |
221 |
| Pathophysiology |
222 |
| Clinical Manifestations |
229 |
| Prognostic Factors |
234 |
| Patient Assessment |
235 |
| Diagnostic Evaluation |
241 |
| Treatment Modalities |
242 |
| Nursing Management |
248 |
| Patient and Caregiver Education |
255 |
| Conclusion |
256 |
| References |
256 |
| Chapter 9. Superior Vena Cava Syndrome |
261 |
| Introduction |
261 |
| Incidence |
261 |
| Risk Factors |
263 |
| Pathophysiology |
263 |
| Clinical Manifestations |
266 |
| Patient Assessment |
268 |
| Prognosis |
269 |
| Diagnostic Evaluation |
270 |
| Treatment Modalities |
271 |
| Nursing Management |
278 |
| Patient and Caregiver Education |
281 |
| Conclusion |
281 |
| References |
282 |
| Chapter 10. Tumor Lysis Syndrome |
285 |
| Introduction |
285 |
| Incidence |
285 |
| Risk Factors |
286 |
| Pathophysiology |
289 |
| Clinical Manifestations |
190 |
| Patient Assessment |
292 |
| Treatment Modalities |
292 |
| Nursing Management |
299 |
| Patient and Caregiver Education |
303 |
| Conclusion |
304 |
| References |
304 |
| Index |
307 |